Covid: India’s First Omicron-Specific Booster Vaccine Gets Drug Controller Nod

The Drug Control General of India (DCGI) has granted emergency use authorisation (EUA) to an Omicron-specific…

‘Works well against Omicrons’, India to get another Covid booster vaccine

Bangla News > outside the house > Covid Omicron Booster Vaccine: ‘Works well against Omicron’, India…

Omicron variant LIVE Updates: All higher education institutions to reopen in Chandigarh on February 1

Image Source: PTI. Healthcare workers administer a booster dose of the Covid vaccine to senior citizens…

Omicron variant LIVE Updates: Scientists debate over need for COVID-specific vaccine

Image Source: PTI. An elderly man receives a third dose or booster dose of Covid vaccine,…

Omicron variant LIVE Updates: Less hospitalisation, less severity in COVID driven wave, say Experts

Image Source: PTI. A healthworker collects swab sample of a commuter for COVID test, amid fear…

Omicron Variant LIVE Updates: It gradually replacing Delta variant in many states, says ICMR official

Image Source: PTI. A healthcare worker collects swab sample of passengers for Covid test, at Bandra…

Gennova Biopharmaceuticals Develops India’s First Homegrown mRNA, Omicron Specific Vaccine

New Delhi: Pune-based Gennova Biopharmaceuticals is developing India’s first homegrown mRNA vaccine that will start trials…

Omicron countdown begins: Human trial of Indian vaccine soon, will target only new corona variant; Pune-based company has prepared

Hindi News Happylife India Coronavirus Omicron Vaccine Latest Update; Pune Gennova Biopharmaceuticals Developed MRNA Vaccine 4…

Vaccine for Omicron? Gennova Pharma Makes India’s 1st Strain-specific Covid-19 Vaccine, Govt to Review Trial Data

Pune-based pharmaceutical manufacturer Gennova Biopharmaceuticals Ltd has almost completed the phase 3 trials of its Covid-19…

AstraZeneca Covid Vaccine As Third Dose Effective Against Omicron, Finds Study

New Delhi: According to preliminary data released by British-Swedish biopharma major AstraZeneca on Thursday, a third…